GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Other Accumulated Expenses (2021 - 2025)

Updated

GT Biopharma's Other Accumulated Expenses was $600,000 in Q1 2025, down 49.3% from the prior quarter.

Analysis

GT Biopharma (GTBP) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

At the end of FY2024, Other Accumulated Expenses at GT Biopharma came in at $1.18 million.

  • Other Accumulated Expenses shows a three-year compound annual growth rate of -42.8% (FY2021 to FY2024).
  • In earlier years, Other Accumulated Expenses was $2.28 million in FY2022 (-64.0%) and $6.34 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 600,000.00
Dec 31, 2024 1.18 Mn
Dec 31, 2022 2.28 Mn
Sep 30, 2022 2.64 Mn
Jun 30, 2022 6.44 Mn
Mar 31, 2022 7.42 Mn
Dec 31, 2021 6.34 Mn
API Access

GT Biopharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GTBP&period=max&api_key=YOUR_API_KEY